focus -WSS

focus

author：leisure time 2025-09-29 22:47:03 - browse：6815

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

entertainment

leisure time

WSS

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Drastic changes should bring profitability, startup health insurers say

Drug cartel violence flares in western Mexico after vigilante leader's killing

'Screen and refer' systems are hurting patients

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

hotspot

focus

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Use doctors trained outside the U.S. to ease the physician shortage

Sports medicine is finally prioritizing gender equality

STAT wants to know your pick for a great summer read or listen

Wildfire smoke exposes gaps in outdoor worker protections

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

State Dept. review finds Biden bears some blame for Afghanistan failures

How Robert F. Kennedy Jr. distorted vaccine science

New air purifier tech could be key to improving indoor air quality

South Korea throws huge K

entertainment

Man killed during FBI raid in connection with threats against Biden, other officials

Naloxone nonprofit donates 200,000 doses after FDA approval

For Cytokinetics, FDA rejection of heart drug would help, not hinder

AstraZeneca lung cancer study comes in below expectations

Drastic changes should bring profitability, startup health insurers say

A letter from the executive editor: The 2023 STATUS List

explore

entertainment

leisure time

knowledge